SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435 | +23.9% | 21,160 | +183.8% | 0.03% | +17.9% |
| Q2 2023 | $351 | -11.1% | 7,457 | -20.8% | 0.03% | -3.4% |
| Q1 2023 | $395 | +20.4% | 9,412 | +9.6% | 0.03% | +7.4% |
| Q4 2022 | $328 | -99.9% | 8,588 | -24.3% | 0.03% | -34.1% |
| Q3 2022 | $444,000 | +26.1% | 11,341 | +4.1% | 0.04% | +28.1% |
| Q2 2022 | $352,000 | +23.1% | 10,895 | +26.2% | 0.03% | +255.6% |
| Q1 2022 | $286,000 | – | 8,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |